[시장보고서]미생물학 및 세균 배양 배지 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 지역별, 부문별 예측(2026-2033년)

미생물학 및 세균 배양 배지 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 지역별, 부문별 예측(2026-2033년)

Microbiology & Bacterial Culture Media Market Size, Share & Trends Analysis Report By Product, By Application, By Region, And Segment Forecasts, 2026 - 2033

상품코드 : 1908209

리서치사 : Grand View Research

발행일 : 2025년 12월

페이지 정보 : 영문 120 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,626,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,076,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 12,976,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

미생물학 및 세균 배양 배지 시장 개요

세계의 미생물학 및 세균 배양 배지 시장 규모는 2025년에 59억 1,000만 달러로 추정되며, 2033년에 118억 3,000만 달러에 달할 것으로 예측됩니다.

2026-2033년 연평균 성장률(CAGR)은 9.19%로 예상됩니다. 이러한 성장은 주로 정확한 질병 진단에 대한 수요 증가, 항균제 내성에 대한 조사 증가, 식품 안전 및 의약품 제조에 대한 미생물 검사 필요성 증가에 의해 주도되고 있습니다.

생명과학과 생명공학의 발전으로 임상 진단, 산업 응용, 학술 연구 분야에서 배양 배지의 활용이 확대되고 있습니다. 또한, 감염병 발생 급증과 바이오의약품 제조 확대에 따라 특수배지 및 강화배지에 대한 수요가 증가하고 있습니다. 이러한 요인에 더해 실험실 워크플로우의 자동화와 미생물학 연구에 대한 정부 자금의 증가가 더해져 세계 시장 성장을 촉진하고 있습니다.

신종 코로나바이러스 감염증(COVID-19)의 팬데믹은 시장에 큰 영향을 미쳤습니다. 진단 검사의 긴급한 수요로 인해 바이러스 감염 검출에 적합한 배양 배지 제품에 대한 수요가 급증했습니다. 이 시기에는 자동 시스템 및 현장 검사 장치 개발을 포함한 미생물 배양 기술의 발전도 가속화되었습니다. 그러나 COVID-19는 전 세계 공급망을 혼란에 빠뜨렸고, 배양 배지 및 관련 장비 공급에 영향을 미쳤습니다. 이러한 어려움에도 불구하고, 백신 개발 및 연구에서 배양 배지의 역할은 그 중요성을 입증하고 있으며, 이 부문에 대한 투자와 혁신이 증가하고 있습니다.

진단용 고품질 배양 배지에 대한 수요 증가도 시장 성장을 가속화하는 주요 요인입니다. 세균 감염, 항균제 내성 병원체, 병원내 감염 등 전 세계적으로 증가하는 감염성 질환에 대응하기 위해 임상 검사실에서는 미생물의 정확한 동정 및 감수성 검사를 보장하는 정밀하고 신뢰할 수 있는 무공해 배지가 요구되고 있습니다. 고급 배양 배지는 일상적인 세균 배양부터 호기성 미생물 및 내성 프로파일링을 수반하는 특수 검사에 이르기까지 다양한 진단 워크플로우를 지원합니다. 그 결과, 의료 서비스 제공자 및 진단 연구소는 성능이 검증되고 품질이 보장된 배지 제품 조달을 우선적으로 고려하고 있습니다.

세계의 미생물학 및 세균 배양 배지 시장의 용도별 변동 분석
세계의 미생물학 및 세균 배양 배지 시장 규모와 동향 분석(용도별, 2021-2033년)
의약품 바이오의약품 생산
진단
식품·수질 검사
- 식품
- 동물 사료
- 수질 검사
바이오에너지 농업 조사
화장품과 퍼스널케어 용도
기타

제6장 미생물학 및 세균 배양 배지 시장 : 지역별, 추정·동향 분석

지역별 시장 점유율 분석(2025년과 2033년)
지역별 시장 대시보드
북미
- 미국
- 캐나다
- 멕시코
서유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 노르웨이
- 스웨덴
- 덴마크
동유럽
- 폴란드
- 헝가리
- 체코
- 불가리아
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 한국
동남아시아
- 태국
- 베트남
- 인도네시아
- 싱가포르
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제7장 경쟁 구도

기업/경쟁 분류
전략 매핑
2025년의 기업의 시장 포지션 분석
기업 개요/리스트
- Merck KGaA
- bioMerieux SA
- HiMedia Laboratories
- Thermo Fisher Scientific Inc.
- BD
- Solabia Group(Biokar diagnostics)
- Titan BIoTech Ltd.
- CONDALAB
- Neogen Corporation
- Bio-Rad Laboratories, Inc.
- SHIMADZU
- Hardy Diagnostics
- R-Biopharm AG
- Alpha Teknova, Inc.
- MP Biomedicals
- Micromaster Laboratories Pvt. Ltd.
- ELEX Biological Products(Shanghai) Co., Ltd.
- Eiken Chemical Co., Ltd.

KSM

영문 목차

영문목차

Microbiology & Bacterial Culture Media Market Summary

The global microbiology & bacterial culture media market size was estimated at USD 5.91 billion in 2025 and is projected to reach USD 11.83 billion by 2033, growing at a CAGR of 9.19% from 2026 to 2033. This growth is primarily driven by the rising demand for accurate disease diagnosis, increased research into antimicrobial resistance, and the growing need for microbial testing in food safety & pharmaceutical production.

Advancements in life sciences and biotechnology have expanded the use of culture media in clinical diagnostics, industrial applications, and academic research. Moreover, the surge in infectious disease outbreaks and the expansion of biopharmaceutical manufacturing have amplified the need for specialized and enriched media. These factors, combined with automation in laboratory workflows and increased government funding for microbiological research, fuel market growth globally.

The COVID-19 pandemic has significantly impacted the market. The urgent need for diagnostic testing led to a surge in demand for culture media products suitable for detecting viral infections. This period also saw accelerated technological advancements in microbiology culture, including the development of automated systems and point-of-care testing devices. However, the pandemic disrupted global supply chains, affecting the availability of culture media and associated equipment. Despite these challenges, the role of culture media in vaccine development and research underscores their importance, leading to increased investment and innovation in the sector.

The increasing demand for high-quality culture media in diagnostic applications is another key driver accelerating market growth. Clinical laboratories require precise, reliable, and contamination-free presses to ensure accurate identification and sensitivity testing of microorganisms with the rising global burden of infectious diseases, including bacterial infections, antimicrobial-resistant pathogens, and hospital-acquired infections. Advanced culture media support various diagnostic workflows, from routine bacterial cultures to specialized tests involving fastidious organisms or resistance profiling. As a result, healthcare providers and diagnostic labs prioritize procuring performance-validated, quality-assured media products.

Global Microbiology & Bacterial Culture Media Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global microbiology & bacterial culture media market report based on product, application, and region:

Product Outlook (Revenue, USD Billion, 2021 - 2033)
Dehydrated Culture Media
Ready-to-use Media
Application Outlook (Revenue, USD Billion, 2021 - 2033)
Pharmaceutical & Biopharmaceutical Production
Diagnostics
Food & Water Testing
- Food
- Animal Feed
- Water Testing
Bioenergy & Agricultural Research
Cosmetics and Personal Care Applications
Others
Regional Outlook (Revenue, USD Billion, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Western Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Eastern Europe
- Poland
- Hungary
- Czech Republic
- Bulgaria
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
Southeast Asia
- Thailand
- Vietnam
- Indonesia
- Singapore
Latin America
- Brazil
- Argentina
Middle East and Africa (MEA)
- South Africa
- UAE
- Saudi Arabia
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Application
1.3. Research Methodology
1.4. Information Procurement
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Microbiology & Bacterial Culture Media Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Growth in global food microbiology testing
  - 3.2.1.2. Rising need for high-quality culture media for diagnostic applications
  - 3.2.1.3. Continuous advancements in biopharmaceutical manufacturing
- 3.2.2. Market restraint analysis
  - 3.2.2.1. High cost of advanced or specialty media
  - 3.2.2.2. Growing preference for alternative methods like molecular diagnostics
3.3. Microbiology & bacterial culture media market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTEL Analysis

Chapter 4. Microbiology & Bacterial Culture Media Market: Product Estimates & Trend Analysis

4.1. Product Segment Dashboard
4.2. Global Microbiology & Bacterial Culture Media Market Product Movement Analysis
4.3. Global Microbiology & Bacterial Culture Media Market Size & Trend Analysis, by Product, 2021 - 2033 (USD Million)
4.4. Dehydrated Culture Media
- 4.4.1. Dehydrated Culture Media Market Size & Forecasts and Trend Analysis, 2021 - 2033 (USD Million)
4.5. Ready-to-use Media
- 4.5.1. Ready-to-use Media Market Size & Forecasts and Trend Analysis, 2021 - 2033 (USD Million)

Chapter 5. Microbiology & Bacterial Culture Media Market: Application Estimates & Trend Analysis

5.1. Application Segment Dashboard
5.2. Global Microbiology & Bacterial Culture Media Market Application Movement Analysis
5.3. Global Microbiology & Bacterial Culture Media Market Size & Trend Analysis, by Application, 2021 - 2033 (USD Million)
5.4. Pharmaceutical & Biopharmaceutical Production
- 5.4.1. Pharmaceutical & Biopharmaceutical Production Market Size & Forecasts and Trend Analyses, 2021 - 2033 (USD Million)
5.5. Diagnostics
- 5.5.1. Diagnostics Market Size & Forecasts and Trend Analyses, 2021 - 2033 (USD Million)
5.6. Food & Water Testing
- 5.6.1. Food & Water Testing Market Size & Forecasts and Trend Analyses, 2021 - 2033 (USD Million)
- 5.6.2. Food
  - 5.6.2.1. Food Market Size & Forecasts and Trend Analyses, 2021 - 2033 (USD Million)
- 5.6.3. Animal Feed
  - 5.6.3.1. Animal Feed Market Size & Forecasts and Trend Analyses, 2021 - 2033 (USD Million)
- 5.6.4. Water Testing
  - 5.6.4.1. Water Testing Market Size & Forecasts and Trend Analyses, 2021 - 2033 (USD Million)
5.7. Bioenergy & Agricultural Research
- 5.7.1. Bioenergy & Agricultural Research Market Size & Forecasts and Trend Analyses, 2021 - 2033 (USD Million)
5.8. Cosmetics and Personal Care Applications
- 5.8.1. Cosmetics and Personal Care Applications Market Size & Forecasts and Trend Analyses, 2021 - 2033 (USD Million)
5.9. Others
- 5.9.1. Others Market Size & Forecasts and Trend Analyses, 2021 - 2033 (USD Million)

Chapter 6. Microbiology & Bacterial Culture Media Market: Regional Estimates & Trend Analysis

6.1. Regional Market Share Analysis, 2025 & 2033
6.2. Regional Market Dashboard
6.3. North America
- 6.3.1. U.S.
  - 6.3.1.1. Key country dynamics
  - 6.3.1.2. Regulatory framework
  - 6.3.1.3. Competitive scenario
  - 6.3.1.4. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.3.2. Canada
  - 6.3.2.1. Key country dynamics
  - 6.3.2.2. Regulatory framework
  - 6.3.2.3. Competitive scenario
  - 6.3.2.4. Canada market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.3.3. Mexico
  - 6.3.3.1. Key country dynamics
  - 6.3.3.2. Regulatory framework
  - 6.3.3.3. Competitive scenario
  - 6.3.3.4. Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
6.4. Western Europe
- 6.4.1. UK
  - 6.4.1.1. Key country dynamics
  - 6.4.1.2. Regulatory framework
  - 6.4.1.3. Competitive scenario
  - 6.4.1.4. UK market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.4.2. Germany
  - 6.4.2.1. Key country dynamics
  - 6.4.2.2. Regulatory framework
  - 6.4.2.3. Competitive scenario
  - 6.4.2.4. Germany market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.4.3. France
  - 6.4.3.1. Key country dynamics
  - 6.4.3.2. Regulatory framework
  - 6.4.3.3. Competitive scenario
  - 6.4.3.4. France market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.4.4. Italy
  - 6.4.4.1. Key country dynamics
  - 6.4.4.2. Regulatory framework
  - 6.4.4.3. Competitive scenario
  - 6.4.4.4. Italy market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.4.5. Spain
  - 6.4.5.1. Key country dynamics
  - 6.4.5.2. Regulatory framework
  - 6.4.5.3. Competitive scenario
  - 6.4.5.4. Spain market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.4.6. Norway
  - 6.4.6.1. Key country dynamics
  - 6.4.6.2. Regulatory framework
  - 6.4.6.3. Competitive scenario
  - 6.4.6.4. Norway market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.4.7. Sweden
  - 6.4.7.1. Key country dynamics
  - 6.4.7.2. Regulatory framework
  - 6.4.7.3. Competitive scenario
  - 6.4.7.4. Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.4.8. Denmark
  - 6.4.8.1. Key country dynamics
  - 6.4.8.2. Regulatory framework
  - 6.4.8.3. Competitive scenario
  - 6.4.8.4. Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
6.5. Eastern Europe
- 6.5.1. Poland
  - 6.5.1.1. Key country dynamics
  - 6.5.1.2. Regulatory framework
  - 6.5.1.3. Competitive scenario
  - 6.5.1.4. Poland market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.5.2. Hungary
  - 6.5.2.1. Key country dynamics
  - 6.5.2.2. Regulatory framework
  - 6.5.2.3. Competitive scenario
  - 6.5.2.4. Hungary market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.5.3. Czech Republic
  - 6.5.3.1. Key country dynamics
  - 6.5.3.2. Regulatory framework
  - 6.5.3.3. Competitive scenario
  - 6.5.3.4. Czech Republic market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.5.4. Bulgaria
  - 6.5.4.1. Key country dynamics
  - 6.5.4.2. Regulatory framework
  - 6.5.4.3. Competitive scenario
  - 6.5.4.4. Bulgaria market estimates and forecasts, 2021 - 2033 (USD Million)
6.6. Asia Pacific
- 6.6.1. Japan
  - 6.6.1.1. Key country dynamics
  - 6.6.1.2. Regulatory framework
  - 6.6.1.3. Competitive scenario
  - 6.6.1.4. Japan market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.6.2. China
  - 6.6.2.1. Key country dynamics
  - 6.6.2.2. Regulatory framework
  - 6.6.2.3. Competitive scenario
  - 6.6.2.4. China market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.6.3. India
  - 6.6.3.1. Key country dynamics
  - 6.6.3.2. Regulatory framework
  - 6.6.3.3. Competitive scenario
  - 6.6.3.4. India market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.6.4. Australia
  - 6.6.4.1. Key country dynamics
  - 6.6.4.2. Regulatory framework
  - 6.6.4.3. Competitive scenario
  - 6.6.4.4. Australia market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.6.5. South Korea
  - 6.6.5.1. Key country dynamics
  - 6.6.5.2. Regulatory framework
  - 6.6.5.3. Competitive scenario
  - 6.6.5.4. South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
6.7. Southeast Asia
- 6.7.1. Thailand
  - 6.7.1.1. Key country dynamics
  - 6.7.1.2. Regulatory framework
  - 6.7.1.3. Competitive scenario
  - 6.7.1.4. Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.7.2. Vietnam
  - 6.7.2.1. Key country dynamics
  - 6.7.2.2. Regulatory framework
  - 6.7.2.3. Competitive scenario
  - 6.7.2.4. Vietnam market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.7.3. Indonesia
  - 6.7.3.1. Key country dynamics
  - 6.7.3.2. Regulatory framework
  - 6.7.3.3. Competitive scenario
  - 6.7.3.4. Indonesia market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.7.4. Singapore
  - 6.7.4.1. Key country dynamics
  - 6.7.4.2. Regulatory framework
  - 6.7.4.3. Competitive scenario
  - 6.7.4.4. Singapore market estimates and forecasts, 2021 - 2033 (USD Million)
6.8. Latin America
- 6.8.1. Brazil
  - 6.8.1.1. Key country dynamics
  - 6.8.1.2. Regulatory framework
  - 6.8.1.3. Competitive scenario
  - 6.8.1.4. Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.8.2. Argentina
  - 6.8.2.1. Key country dynamics
  - 6.8.2.2. Regulatory framework
  - 6.8.2.3. Competitive scenario
  - 6.8.2.4. Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
6.9. MEA
- 6.9.1. South Africa
  - 6.9.1.1. Key country dynamics
  - 6.9.1.2. Regulatory framework
  - 6.9.1.3. Competitive scenario
  - 6.9.1.4. South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.9.2. Saudi Arabia
  - 6.9.2.1. Key country dynamics
  - 6.9.2.2. Regulatory framework
  - 6.9.2.3. Competitive scenario
  - 6.9.2.4. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.9.3. UAE
  - 6.9.3.1. Key country dynamics
  - 6.9.3.2. Regulatory framework
  - 6.9.3.3. Competitive scenario
  - 6.9.3.4. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.9.4. Kuwait
  - 6.9.4.1. Key country dynamics
  - 6.9.4.2. Regulatory framework
  - 6.9.4.3. Competitive scenario
  - 6.9.4.4. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

7.1. Company/Competition Categorization
7.2. Strategy Mapping
7.3. Company Market Position Analysis, 2025
7.4. Company Profiles/Listing
- 7.4.1. Merck KGaA
  - 7.4.1.1. Company overview
  - 7.4.1.2. Financial performance
  - 7.4.1.3. Product benchmarking
  - 7.4.1.4. Strategic initiatives
- 7.4.2. bioMerieux SA
  - 7.4.2.1. Company overview
  - 7.4.2.2. Financial performance
  - 7.4.2.3. Product benchmarking
  - 7.4.2.4. Strategic initiatives
- 7.4.3. HiMedia Laboratories
  - 7.4.3.1. Company overview
  - 7.4.3.2. Financial performance
  - 7.4.3.3. Product benchmarking
  - 7.4.3.4. Strategic initiatives
- 7.4.4. Thermo Fisher Scientific Inc.
  - 7.4.4.1. Company overview
  - 7.4.4.2. Financial performance
  - 7.4.4.3. Product benchmarking
  - 7.4.4.4. Strategic initiatives
- 7.4.5. BD
  - 7.4.5.1. Company overview
  - 7.4.5.2. Financial performance
  - 7.4.5.3. Product benchmarking
  - 7.4.5.4. Strategic initiatives
- 7.4.6. Solabia Group (Biokar diagnostics)
  - 7.4.6.1. Company overview
  - 7.4.6.2. Financial performance
  - 7.4.6.3. Product benchmarking
  - 7.4.6.4. Strategic initiatives
- 7.4.7. Titan Biotech Ltd.
  - 7.4.7.1. Company overview
  - 7.4.7.2. Financial performance
  - 7.4.7.3. Product benchmarking
  - 7.4.7.4. Strategic initiatives
- 7.4.8. CONDALAB
  - 7.4.8.1. Company overview
  - 7.4.8.2. Financial performance
  - 7.4.8.3. Product benchmarking
  - 7.4.8.4. Strategic initiatives
- 7.4.9. Neogen Corporation
  - 7.4.9.1. Company overview
  - 7.4.9.2. Financial performance
  - 7.4.9.3. Product benchmarking
  - 7.4.9.4. Strategic initiatives
- 7.4.10. Bio-Rad Laboratories, Inc.
  - 7.4.10.1. Company overview
  - 7.4.10.2. Financial performance
  - 7.4.10.3. Product benchmarking
  - 7.4.10.4. Strategic initiatives
- 7.4.11. SHIMADZU
  - 7.4.11.1. Company overview
  - 7.4.11.2. Financial performance
  - 7.4.11.3. Product benchmarking
  - 7.4.11.4. Strategic initiatives
- 7.4.12. Hardy Diagnostics
  - 7.4.12.1. Company overview
  - 7.4.12.2. Financial performance
  - 7.4.12.3. Product benchmarking
  - 7.4.12.4. Strategic initiatives
- 7.4.13. R-Biopharm AG
  - 7.4.13.1. Company overview
  - 7.4.13.2. Financial performance
  - 7.4.13.3. Product benchmarking
  - 7.4.13.4. Strategic initiatives
- 7.4.14. Alpha Teknova, Inc.
  - 7.4.14.1. Company overview
  - 7.4.14.2. Financial performance
  - 7.4.14.3. Product benchmarking
  - 7.4.14.4. Strategic initiatives
- 7.4.15. MP Biomedicals
  - 7.4.15.1. Company overview
  - 7.4.15.2. Financial performance
  - 7.4.15.3. Product benchmarking
  - 7.4.15.4. Strategic initiatives
- 7.4.16. Micromaster Laboratories Pvt. Ltd.
  - 7.4.16.1. Company overview
  - 7.4.16.2. Financial performance
  - 7.4.16.3. Product benchmarking
  - 7.4.16.4. Strategic initiatives
- 7.4.17. ELEX Biological Products (Shanghai) Co., Ltd.
  - 7.4.17.1. Company overview
  - 7.4.17.2. Financial performance
  - 7.4.17.3. Product benchmarking
  - 7.4.17.4. Strategic initiatives
- 7.4.18. Eiken Chemical Co., Ltd.
  - 7.4.18.1. Company overview
  - 7.4.18.2. Financial performance
  - 7.4.18.3. Product benchmarking
  - 7.4.18.4. Strategic initiatives

한글목차

미생물학 및 세균 배양 배지 시장 개요

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 미생물학 및 세균 배양 배지 시장 변수, 동향, 범위

제4장 미생물학 및 세균 배양 배지 시장 : 제품별, 추정·동향 분석

제5장 미생물학 및 세균 배양 배지 시장 : 용도별, 추정·동향 분석